JP2002518011A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002518011A5 JP2002518011A5 JP2000554853A JP2000554853A JP2002518011A5 JP 2002518011 A5 JP2002518011 A5 JP 2002518011A5 JP 2000554853 A JP2000554853 A JP 2000554853A JP 2000554853 A JP2000554853 A JP 2000554853A JP 2002518011 A5 JP2002518011 A5 JP 2002518011A5
- Authority
- JP
- Japan
- Prior art keywords
- bpi
- analog
- host cell
- deleted
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100033735 Bactericidal permeability-increasing protein Human genes 0.000 description 9
- 101000871785 Homo sapiens Bactericidal permeability-increasing protein Proteins 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 3
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 102000052586 bactericidal permeability increasing protein Human genes 0.000 description 1
- 108010032816 bactericidal permeability increasing protein Proteins 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/099,725 US6013631A (en) | 1998-06-19 | 1998-06-19 | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
| US09/099,725 | 1998-06-19 | ||
| PCT/US1999/013860 WO1999066044A1 (en) | 1998-06-19 | 1999-06-18 | Bactericidal/permeability-increasing protein (bpi) deletion analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002518011A JP2002518011A (ja) | 2002-06-25 |
| JP2002518011A5 true JP2002518011A5 (cg-RX-API-DMAC7.html) | 2006-06-29 |
Family
ID=22276330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000554853A Pending JP2002518011A (ja) | 1998-06-19 | 1999-06-18 | 殺菌性/透過性増加タンパク質(bpi)欠失アナログ |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US6013631A (cg-RX-API-DMAC7.html) |
| EP (1) | EP1086230A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002518011A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1273598C (cg-RX-API-DMAC7.html) |
| AU (1) | AU755624B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2331880A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA00011398A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ508816A (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999066044A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5198541A (en) * | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
| US6013631A (en) * | 1998-06-19 | 2000-01-11 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
| WO2000071149A2 (en) * | 1999-05-24 | 2000-11-30 | Xoma (Us) Llc | Therapeutic uses of bpi protein products in humans with otitis media with effusion |
| JP2004517865A (ja) * | 2000-12-01 | 2004-06-17 | ゾーマ テクノロジー リミテッド | Bpiタンパク質産物またはbpiインヒビターを使用する、周皮細胞増殖の調節 |
| ATE496134T1 (de) | 2002-03-29 | 2011-02-15 | Xoma Technology Ltd | Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden |
| AU2004216298B2 (en) * | 2003-02-28 | 2009-04-23 | Chugai Seiyaku Kabushiki Kaisha | Stabilized protein-containing formulations |
| EP1891207A2 (en) * | 2005-06-03 | 2008-02-27 | Biovitrum AB | Process for cultivating animal cells comprising the feeding of plant-derived peptones |
| EP1741440A1 (en) | 2005-07-08 | 2007-01-10 | Mellitus S.L. | Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders |
| US8338376B2 (en) * | 2006-10-20 | 2012-12-25 | Biogen Idec Ma Inc. | Compositions comprising variant LT-B-R-IG fusion proteins |
| CA2680792A1 (en) * | 2007-03-15 | 2008-09-18 | Biogen Idec Ma Inc. | Treatment of autoimmune disorders |
| EP2694084B1 (en) | 2011-04-05 | 2016-03-23 | Dana-Farber Cancer Institute, Inc. | Bpi and its congeners as radiation mitigators and radiation protectors |
| GB201319621D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Antimicrobial agents and their use in therapy |
| GB201319620D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Immunosuppressive agents and their use in therapy |
| KR102270048B1 (ko) * | 2020-07-10 | 2021-06-28 | 주식회사 녹십자 | 바리셀라 조스터 바이러스 표면 단백질 항원의 생산 방법 |
| CN115947868B (zh) * | 2022-09-28 | 2026-05-12 | 安君(北京)基因科技有限责任公司 | Cxcl-bpi融合蛋白及其用途 |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5198541A (en) * | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
| US5576292A (en) * | 1987-08-11 | 1996-11-19 | New York University | Biologically active bactericidal/permeability-increasing protein fragments |
| US5334584A (en) * | 1989-02-14 | 1994-08-02 | Incyte Pharamaceuticals, Inc. | Recombinant, non-glycosylated bpi protein and uses thereof |
| US5234912A (en) * | 1989-02-14 | 1993-08-10 | Incyte Pharmaceuticals, Inc. | Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
| US5770694A (en) * | 1990-08-13 | 1998-06-23 | Incyte Pharmaceuticals, Inc. | Genetically engineered BPI variant proteins |
| US5089274A (en) * | 1989-02-14 | 1992-02-18 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
| US5308834A (en) * | 1989-02-14 | 1994-05-03 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and prevention thereof using a BPI protein |
| US5171739A (en) * | 1989-02-14 | 1992-12-15 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
| WO1992009621A1 (en) * | 1990-12-03 | 1992-06-11 | New York University | Biologically active bactericidal/permeability-increasing protein fragments |
| EP0605653A4 (en) * | 1991-09-26 | 1995-03-15 | Incyte Pharma Inc | NEW LIPOSACCHARID BINDING PROTEIN (LBP). |
| WO1993023434A2 (en) * | 1992-05-19 | 1993-11-25 | Xoma Corporation | Bpi-immunoglobulin fusion proteins |
| US5439807A (en) * | 1992-05-19 | 1995-08-08 | Xoma Corporation | Methods for the preparation of endotoxin-binding proteins |
| US5420019A (en) * | 1993-02-02 | 1995-05-30 | Xoma Corporation | Stable bactericidal/permeability-increasing protein muteins |
| US5488034A (en) * | 1993-02-02 | 1996-01-30 | Xoma Corporation | Pharmaceutical composition comprising BPI proteins |
| WO1994019323A1 (en) | 1993-02-18 | 1994-09-01 | Merck Sharp & Dohme Limited | Azacyclic compounds, compositions containing them and their use as tachykinin antagonists |
| US5733872A (en) * | 1993-03-12 | 1998-03-31 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| CA2157927C (en) * | 1993-03-12 | 1999-03-30 | Xoma Corporation | Therapeutic uses of bactericidal/permeability increasing protein produc ts |
| DK0690872T3 (da) * | 1993-03-12 | 1999-05-10 | Xoma Corp | Biologisk aktive peptider fra funktionelle domæner af baktericidt/permeabilitetsforøgende protein og anvendelser deraf |
| US5652332A (en) * | 1993-03-12 | 1997-07-29 | Xoma | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| US5348942A (en) * | 1993-03-12 | 1994-09-20 | Xoma Corporation | Therapeutic uses of bactericidal/permeability increasing protein products |
| ES2119185T3 (es) * | 1993-03-12 | 1998-10-01 | Xoma Corp | Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad. |
| AU6522794A (en) * | 1993-03-22 | 1994-10-11 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis |
| AU6942994A (en) * | 1993-04-30 | 1994-11-21 | Incyte Pharmaceuticals, Inc. | Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof |
| US5731415A (en) * | 1993-06-17 | 1998-03-24 | Xoma Corporation | Lipopolysaccharide binding protein derivatives |
| EP0726944B1 (en) * | 1993-07-02 | 2002-12-18 | Incyte Pharmaceuticals, Inc. | Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
| AU7330994A (en) * | 1993-07-14 | 1995-02-13 | Xoma Corporation | Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products |
| US5770561A (en) * | 1993-07-14 | 1998-06-23 | Xoma Corporation | Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products |
| US5466580A (en) * | 1993-09-22 | 1995-11-14 | Xoma Corporation | Method for quantifying BPI in body fluids |
| DK0759774T3 (da) * | 1993-09-22 | 2002-10-07 | Xoma Technology Ltd | Fremgangsmåde til behandling af gram-negativ bakteriel infektion ved indgivelse af baktericidt/permeabilitet-forøgende (BPI) proteinprodukt og antibiotikum |
| CN1133634A (zh) * | 1993-09-22 | 1996-10-16 | 爱克斯欧玛公司 | 定量体液中的bpi的方法 |
| ZA947783B (en) * | 1993-10-15 | 1996-05-05 | Xoma Corp | Method of treating depressed reticuloendothelial system function |
| CA2181164C (en) * | 1994-01-14 | 2008-01-08 | Arnold Horwitz | Anti-gram-positive bacterial methods and materials |
| WO1995019179A1 (en) * | 1994-01-14 | 1995-07-20 | Xoma Corporation | Anti-fungal methods and materials |
| US5484705A (en) * | 1994-01-24 | 1996-01-16 | Xoma Corporation | Method for quantifying lipopolysaccharide binding protein |
| US5643875A (en) * | 1994-01-24 | 1997-07-01 | Friedmann; Nadav | Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| US5447913A (en) * | 1994-03-11 | 1995-09-05 | Xoma Corporation | Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| US5786324A (en) * | 1994-03-24 | 1998-07-28 | Regents Of The University Of Minnesota | Synthetic peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use |
| US5578568A (en) * | 1994-04-22 | 1996-11-26 | Xoma Corporation | Method of treating conditions associated with intestinal ischemia/reperfusion |
| US5532216A (en) * | 1994-06-24 | 1996-07-02 | Incyte Pharmaceuticals, Inc. | Neutralization of non-lipopolysaccharide compounds by bactericidal/permeability-increasing protein |
| US5646114A (en) * | 1994-07-11 | 1997-07-08 | Xoma Corporation | Anti-protozoan methods |
| DE69532302D1 (de) * | 1994-09-15 | 2004-01-22 | Xoma Technology Ltd | Peptide gegen pilzen |
| US5912228A (en) * | 1995-01-13 | 1999-06-15 | Xoma Corporation | Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products |
| US5494896A (en) * | 1995-03-31 | 1996-02-27 | Xoma Corporation | Method of treating conditions associated with burn injuries |
| WO1997004008A1 (en) * | 1995-07-20 | 1997-02-06 | Xoma Corporation | Anti-fungal peptides |
| US5686414A (en) * | 1995-11-14 | 1997-11-11 | Xoma Corporation | Methods of treating conditions associated with corneal transplantation |
| CA2235626C (en) * | 1995-11-14 | 2002-01-01 | Xoma Corporation | Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| AU735058B2 (en) * | 1996-05-10 | 2001-06-28 | Xoma Corporation | Therapeutic uses of BPI protein products for human meningococcemia |
| US5741779A (en) * | 1996-05-10 | 1998-04-21 | Xoma Corporation | Antithrombotic materials and methods |
| ATE234111T1 (de) * | 1996-05-23 | 2003-03-15 | Xoma Technology Ltd | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung |
| US5888973A (en) * | 1996-08-09 | 1999-03-30 | Xoma Corporation | Anti-chlamydial uses of BPI protein products |
| EP1304118A3 (en) * | 1996-11-01 | 2004-01-14 | XOMA Technology Ltd. | Therapeutic uses and formulations for BPI protein products. |
| US6013631A (en) * | 1998-06-19 | 2000-01-11 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
-
1998
- 1998-06-19 US US09/099,725 patent/US6013631A/en not_active Expired - Lifetime
-
1999
- 1999-06-18 EP EP99930432A patent/EP1086230A1/en not_active Withdrawn
- 1999-06-18 JP JP2000554853A patent/JP2002518011A/ja active Pending
- 1999-06-18 CN CNB998097268A patent/CN1273598C/zh not_active Expired - Fee Related
- 1999-06-18 MX MXPA00011398A patent/MXPA00011398A/es unknown
- 1999-06-18 NZ NZ508816A patent/NZ508816A/xx unknown
- 1999-06-18 CA CA002331880A patent/CA2331880A1/en not_active Abandoned
- 1999-06-18 US US09/336,402 patent/US6087126A/en not_active Expired - Fee Related
- 1999-06-18 AU AU46976/99A patent/AU755624B2/en not_active Ceased
- 1999-06-18 WO PCT/US1999/013860 patent/WO1999066044A1/en not_active Ceased
-
2000
- 2000-05-25 US US09/579,403 patent/US6599880B1/en not_active Expired - Fee Related
-
2003
- 2003-07-29 US US10/629,516 patent/US20050130889A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003530839A5 (cg-RX-API-DMAC7.html) | ||
| ES2426420T3 (es) | Péptidos de queratina bioactivos | |
| JP2004501618A5 (cg-RX-API-DMAC7.html) | ||
| JPH10502360A (ja) | ヒトインターロイキン4のアンタゴニストもしくは部分的アゴニストとして用いられる新規hIL−4突然変異蛋白質 | |
| EP1310558A3 (en) | Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same | |
| CA2230885A1 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
| CZ350296A3 (en) | Polypetides and pharmaceutical compositions containing thereof | |
| EP1548028A4 (en) | SUBSTITUTED WT1 PEPTIDES | |
| MY123371A (en) | Protein for blocking platelet adhesion | |
| ES2279510T3 (es) | Generacion de insulina humana. | |
| HRP20170755T1 (hr) | Rekombinantni proteini elastaze i postupci proizvodnje i uporabe istih | |
| NO20013608L (no) | DNA-klon for human vevsfaktorinhibitor | |
| DK170346B1 (da) | Granulocyt-makrofag-"Colony Stimulating"-faktor(CSF)-proteiner, fremgangsmåde til fremstilling deraf, ekspressionsvektor og E.coli-celle til brug ved denne fremgangsmåde samt anvendelse af disse proteiner | |
| WO2004022003A3 (en) | Materials and methods for treatment of allergic diseases | |
| HU0000992D0 (en) | Genetically engineered cell culture adapted infections bursal diseases virus (ibdv)mutants | |
| KR880009125A (ko) | 재조합 숙주에 의해 제조되는 췌장분비 트립신 억제제 및 그의 변이체, 그의 방법, 표현벡터 및 재조합 숙주 및 그의 제약상 용도 | |
| DE68926679D1 (de) | Physiologisch aktives polypeptid, rekombinantes plasmid, rekombinante mikrobielle zellen, medizinisches präparat sowie verfahren zur gewinnung des gereinigten polypeptids | |
| JP2001029093A (ja) | インターロイキン−1インヒビター | |
| JP2005519591A (ja) | 毛包成長 | |
| JP2005053929A (ja) | 肺胞界面活性タンパク質 | |
| NZ508816A (en) | Bactericidal/permeability-increasing protein (BPI) deletion analogs | |
| EP1209226A3 (en) | Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70) | |
| CA2011008C (en) | Egf variants and pharmaceutical use thereof | |
| JPWO2016084935A1 (ja) | Iii型コラーゲン産生促進剤 | |
| CA2423616A1 (en) | Chemokine mutants in the treatment of multiple sclerosis |